Portal de Periódicos da CAPES

Why Should American Headache and Migraine Patients Still Be Treated With Butalbital‐Containing Medicine?

2012; Wiley; Volume: 52; Issue: 4 Linguagem: Inglês

10.1111/j.1526-4610.2012.02115.x

1526-4610

Peer Tfelt‐Hansen, Hans‐Christoph Diener,

Trigeminal Neuralgia and Treatments

Why Should American Headache and Migraine Patients Still Be Treated With Butalbital-Containing Medicine? Peer Carsten Tfelt-Hansen MD, DMSc, Corresponding Author Peer Carsten Tfelt-Hansen MD, DMSc From the Danish Headache Center, Department of Neurology, Glostrup Hospital, Glostrup, Denmark (P.C. Tfelt-Hansen); Department of Neurology, University of Essen, Essen, Germany (H-C. Diener).Peer C. Tfelt-Hansen, Department of Neurology N39, Glostrup Hospital, 2600 Glostrup, Denmark.Search for more papers by this authorHans-Christoph Diener MD, DMSc, Hans-Christoph Diener MD, DMSc From the Danish Headache Center, Department of Neurology, Glostrup Hospital, Glostrup, Denmark (P.C. Tfelt-Hansen); Department of Neurology, University of Essen, Essen, Germany (H-C. Diener).Search for more papers by this author Peer Carsten Tfelt-Hansen MD, DMSc, Corresponding Author Peer Carsten Tfelt-Hansen MD, DMSc From the Danish Headache Center, Department of Neurology, Glostrup Hospital, Glostrup, Denmark (P.C. Tfelt-Hansen); Department of Neurology, University of Essen, Essen, Germany (H-C. Diener).Peer C. Tfelt-Hansen, Department of Neurology N39, Glostrup Hospital, 2600 Glostrup, Denmark.Search for more papers by this authorHans-Christoph Diener MD, DMSc, Hans-Christoph Diener MD, DMSc From the Danish Headache Center, Department of Neurology, Glostrup Hospital, Glostrup, Denmark (P.C. Tfelt-Hansen); Department of Neurology, University of Essen, Essen, Germany (H-C. Diener).Search for more papers by this author First published: 08 March 2012 https://doi.org/10.1111/j.1526-4610.2012.02115.xCitations: 9 Conflict of Interest: The authors report no conflict of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Derosier F, Sheftell F, Silberstein S, et al. Sumatriptan-naproxen and butalbital, a double-blind, placebo-controlled crossover. Headache. 2011. [Epub ahead of print]. doi: 10.1111/j.1526-4610.2011.02039.x. Web of Science®Google Scholar 2 Silberstein SD, McCrory DC. Butalbital in the treatment of headache: History, pharmacology, and efficacy. Headache. 2001; 41: 953-967. 10.1046/j.1526-4610.2001.01189.x CASPubMedWeb of Science®Google Scholar 3 Goldstein J, Gawel MJ, Winner P, et al; on behalf of Stadol Nasal Spray/Fliorinal C Study Group. Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine. Headache. 1998; 38: 516-522. 10.1046/j.1526-4610.1998.3807516.x CASPubMedWeb of Science®Google Scholar 4 Silberstein SD. Practice parameter: Evidence-based Guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55: 754-762. 10.1212/WNL.55.6.754 CASPubMedWeb of Science®Google Scholar 5 Wenzel RG, Sarvis CA. Do butalbital-containing products have a role in the management of migraine? Pharmacotherapy. 2002; 22: 1029-1035. 10.1592/phco.22.12.1029.33595 CASPubMedWeb of Science®Google Scholar 6 Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary centre – clinical characteristics and treatment outcome. Cephalalgia. 2004; 24: 483-490. 10.1111/j.1468-2982.2004.00691.x CASPubMedWeb of Science®Google Scholar 7 Loder E. Fixed drug combinations for the acute treatment of migraine: Place in therapy. CNS Drugs. 2005; 19: 769-784. 10.2165/00023210-200519090-00004 CASPubMedWeb of Science®Google Scholar 8 Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: A multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2005; 25: 776-787. 10.1111/j.1468-2982.2005.00948.x CASPubMedWeb of Science®Google Scholar 9 Diener H-C, Silberstein SD. Medication overuse headaches. In: J Olesen, PJ Goadsby, NM Ramadan, P Tfelt-Hansen, KMA Welch, eds. The Headaches, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 971-979. Google Scholar 10 HC Diener, M Wilkinson, eds. Drug-Induced Headache. Berlin, Heidelberg, New-York: Springer; 1988. 10.1007/978-3-642-73327-7 Google Scholar Citing Literature Volume52, Issue4April 2012Pages 672-674 ReferencesRelatedInformation